Development of afucosylated monoclonal antibodies with enhanced effector functions to combat malaria Grant

Development of afucosylated monoclonal antibodies with enhanced effector functions to combat malaria .

date/time interval

  • September 1, 2022 - August 31, 2023

awarded by

subcontracted through

administered by

sponsor award ID

  • Agreement signed 11/2022

local award ID

  • AWD000000013689

contributor

  • Li, Jun   Principal Investigator